Neonatal and Adult Cardiovascular Pathophysiological Remodeling and Repair
- 19 March 2008
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1123 (1), 30-40
- https://doi.org/10.1196/annals.1420.005
Abstract
The neonatal heart undergoes normal hypertrophy or compensation to complete development and adapt to increased systolic pressures. Hypertrophy and increased neonatal wall stiffness are associated with a doubling of the number of fibroblasts and de novo formation of collagen. Normal postnatal remodeling is completed within 3-4 weeks after birth but can be rekindled in adult life in response to environmental signals that lead to pathological hypertrophy, fibrosis, and heart failure. The signals that trigger fibroblast and collagen formation (fibrosis) as well as the origin and differentiation of the cardiac fibroblast lineage are not well understood. Using mice studies and a single-cell engraftment model, we have shown that cardiac fibroblasts are derived from two extracardiac sources: the embryonic proepicardial organ and the recruitment of circulating bone marrow cells of hematopoietic stem cell origin. Periostin, a matricellular protein, is normally expressed in differentiating fibroblasts but its expression is elevated several fold in pathological remodeling and heart failure. Our hypothesis that periostin is profibrogenic (i.e., it promotes differentiation of progenitor mesenchymal cells into fibroblasts and their secretion and compaction of collagen) was tested using isolated and cultured embryonic, neonatal, and adult wild-type and periostin-null, nonmyocyte populations. Our findings indicate that abrogation of periostin by targeted gene deletion inhibits differentiation of nonmyocyte progenitor cells or permits misdirection into a cardiomyocyte lineage. However, if cultured with periostin or forced to express periostin, they became fibroblasts. Periostin plays a significant role in promoting fibrogenesis residual stress, and tensile testings indicated that periostin played an essential regulatory role in maintaining the biomechanical properties of the adult myocardium. These findings indicate that periostin is a profibrogenic matricellular protein that promotes collagen fibrogenesis, inhibits differentiation of progenitor cells into cardiomyocytes, and is essential for maintaining the biomechanical properties of the adult myocardium.This publication has 50 references indexed in Scilit:
- Determination of cell types and numbers during cardiac development in the neonatal and adult rat and mouseAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Genetic Manipulation of Periostin Expression Reveals a Role in Cardiac Hypertrophy and Ventricular RemodelingCirculation Research, 2007
- Novel Mechanisms of Valsartan on the Treatment of Acute Myocardial Infarction Through Inhibition of the Antiadhesion Molecule PeriostinHypertension, 2007
- Periostin regulates collagen fibrillogenesis and the biomechanical properties of connective tissuesJournal of Cellular Biochemistry, 2007
- The Matricellular Protein CCN1 Is Essential for Cardiac DevelopmentCirculation Research, 2006
- Periostin promotes atrioventricular mesenchyme matrix invasion and remodeling mediated by integrin signaling through Rho/PI 3-kinaseDevelopmental Biology, 2006
- Complex distributions of residual stress and strain in the mouse left ventricle: experimental and theoretical modelsBiomechanics and Modeling in Mechanobiology, 2003
- Embryonic Smooth Muscle Myosin Heavy Chain SMemb is Expressed in Pressure-Overloaded Cardiac Fibroblasts.Japanese Heart Journal, 1999
- Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo.The Journal of Experimental Medicine, 1996
- Recognition of extracellular matrix components by neonatal and adult cardiac myocytesDevelopmental Biology, 1984